What a year!
It is hard to believe the year end is upon us in what seems like a flash, and how much we have delivered in the tail end of the year as we resume face-to-face life. The general feeling from the people we speak with is that they are tired and in the same breath looking forward to the new year. What is most important is that people are optimistic about the future and focused on taking the necessary time out to re-energise and start the new year brighter and with resolve to have a strong and positive impact in 2023.
Since its inception Cardihab has been paving the way for Digital Cardiac Rehabilitation to become a core part of clinician workflows so that more patients have a better road to recovery post cardiac event and/or procedure.
This year we have celebrated numerous milestone achievements and heard heartening accounts from patients and clinicians who have benefited from our programs. A new publication in JMIR arrived earlier in the year, reinforcing the impact we can have on improving patient uptake, and signaling important insights for hospital readmission rate reductions. New real world evidence was also presented at a range of scientific congresses in Australia and the US, with uptake in local media and publications pending.
We were thrilled to begin our journey in the inaugural ANDHealth+ program, and initiated our collaboration with Queensland Cardiovascular Group’s Atrial Fibrillation Institute. With thanks to funding from the Targeted Translation Research Accelerator (TTRA), we began our journey towards a Heart Failure specific digital therapeutic in partnership with the Baker Heart and Diabetes Institute.
As we come to the end of 2022 I am both humbled and proud to be part of the Cardihab mission and thankful for the wonderful team of passionate and dedicated people that I work with each and every day. We often reflect on the impact we are making with people that work tirelessly on improving access to cardiac rehabilitation across Australia.
In collaboration with customers, partners, suppliers and through the important support from our investors and grant funding, the opportunities we are creating will not only propel Cardihab’s impact for patients, but elevate the capabilities within the Australian ecosystem to deliver quality digital therapeutics that change the way we manage cardiovascular disease in Australia.
On behalf of the Cardihab team I would like to sincerely thank you all for your support and commitment throughout the year. We wish you a happy and safe Christmas, and an energised and prosperous New Year.
All the best,